Roche Diabetes Care AG Sustainability Profile
Roche Diabetes Care AG, a subsidiary of the global healthcare leader Roche Holding AG, is headquartered in Switzerland (CH) and operates extensively across Europe, North America, and Asia. Founded in 1896, Roche has established itself as a pioneer in the diabetes care industry, focusing on innovative solutions that enhance the management of diabetes. The company is renowned for its comprehensive portfolio of blood glucose monitoring systems, insulin delivery devices, and digital health solutions. Roche Diabetes Care's unique approach combines advanced technology with user-friendly design, ensuring patients and healthcare professionals can effectively manage diabetes. With a strong market position, Roche Diabetes Care AG has achieved significant milestones, including the development of the Accu-Chek product line, which is widely recognised for its accuracy and reliability. The company continues to lead in diabetes management, committed to improving patient outcomes through innovation and quality care.
DitchCarbon Score
How does Roche Diabetes Care AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roche Diabetes Care AG's score of 84 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roche Diabetes Care AG, headquartered in Switzerland (CH), currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Roche Holding AG, any climate commitments or emissions data would be inherited from its parent company. Roche Holding AG has set ambitious climate targets, which may influence Roche Diabetes Care AG's sustainability initiatives. However, specific reduction targets or achievements for Roche Diabetes Care AG are not detailed in the available information. The company is part of a broader corporate commitment to sustainability, but without specific emissions data or reduction initiatives outlined for Roche Diabetes Care AG, it is challenging to provide a comprehensive overview of its carbon footprint or climate commitments. For further insights, it is advisable to refer to Roche Holding AG's sustainability reports or climate strategies, as these may provide relevant context and data cascaded to Roche Diabetes Care AG.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 403,136,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 188,924,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Roche Diabetes Care AG's Industry?
How Carbon Intensive is Roche Diabetes Care AG's Location?
Roche Diabetes Care AG's Scope 3 Categories Breakdown
Roche Diabetes Care AG's Scope 3 emissions, which decreased by 8% last year and increased significantly since 2013, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Top Scope 3 Categories
Roche Diabetes Care AG's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Roche Diabetes Care AG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
